CDH1 and cancer: Our liquid biopsy detected a CDH1 mutation in the case #2 patient after 7 months of treatment before the CT scan, which revealed cancer recurrence and pelvic lymph node metastases, indicating that liquid biopsy may have the ability to find clues of cancer recurrence and metastasis before traditional imaging examinations.